Experimental Lupus Drug Blisibimod Enrolling Patients in Late-stage Overseas Study
Thursday, March 28, 2013
Patients in Asia, Commonwealth of Independent States and Latin America have an opportunity to take part in a new study of the investigational drug blisibimod for SLE.
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms